Table 2.

Mean changes in primary and secondary outcome variables in the STEPS and control groups at 12 months

VARIABLESSTEPS (N = 169*) MEAN CHANGE (95% CI)CONTROL (N = 160) MEAN CHANGE (95% CI)DIFFERENCE BETWEEN GROUPS IN MEAN CHANGE (95% CI)PVALUE FOR THE DIFFERENCE BETWEEN GROUPS
pVO2max, mL/kg/min3.02 (2.40 to 3.65)2.21 (1.27 to 3.15)0.81 (−0.29 to 1.91).147
HRmax, beats/min8.27 (5.70 to 10.84)4.22 (0.91 to 7.54)4.05 (−0.09 to 8.18).055
Stepping time, s−19.05 (−21.35 to −16.74)−10.77 (−14.20 to −7.35)−8.28 (−12.32 to −4.24)< .001
RPE, Borg score0.93 (0.61 to 1.25)0.50 (0.18 to 0.82)0.43 (−0.02 to 0.88).061
BMI, kg/m20.13 (−0.08 to 0.35)−0.17 (−0.46 to 0.12)0.30 (−0.05 to 0.66).095
HRrest, beats/min1.23 (−0.15 to 2.61)1.70 (0.18 to 3.23)−0.47 (−2.52 to 1.57).648
SBPrest, mm Hg−4.13 (−6.39 to −1.86)−0.38 (−2.98 to 2.22)−3.75 (−7.17 to −0.32).032
DBPrest, mm Hg−1.93 (−3.22 to −0.63)−1.67 (−3.23 to −0.10)−0.26 (−2.27 to 1.76).801
EE, kcal/kg/d0.67 (0.43 to 0.91)0.25 (0.07 to 0.42)0.42 (0.12 to 0.72).006
  • BMI—body mass index, CI—confidence interval, DBPrest—resting diastolic blood pressure, EE—energy expenditure, HRmax—maximum heart rate, HRrest—resting heart rate, pVO2max—predicted maximal oxygen consumption, RPE—rate of perceived exertion, SBPrest—resting systolic blood pressure.

  • * In the STEPS group, 23 of the original 193 patients withdrew, and 1 died of causes not related to the study.

  • In the control group, 6 of the original 167 patients withdrew, and 1 died of causes not related to the study.